ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, ...

For nearly 35 years, musician Ani DiFranco has graced the world with her music. With more than 20 albums released to date, ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great ...

Q1 2025 Management View CEO Nikhil Lalwani highlighted a strong start to 2025, marked by record revenue, adjusted EBITDA, and ...

ANIP is expected to raise 2025 guidance due to FDA approval and launch of TEZRULY and INZIRQO, addressing unmet needs for ...

ANI Pharmaceuticals ANIP Get Free Report is gearing up to announce its quarterly earnings on Friday, 2025-05-09. Here's a ...

ANI expects full-year earnings in the range of $6.27 to $6.62 per share, with revenue in the range of $768 million to $793 million. ANI shares have climbed 29% since the beginning of the year. The ...

Increased 2025 guidance with expected net revenues of $768.0 million to $793.0 million, adjusted non-GAAP EBITDA of $195.0 ...

BAUDETTE, Minn. (AP) — BAUDETTE, Minn. (AP) — ANI Pharmaceuticals Inc. (ANIP) on Friday reported first-quarter earnings of $15.7 million. The Baudette, Minnesota-based company said it had ...

ANI expects full-year earnings in the range of $6.27 to $6.62 per share, with revenue in the range of $768 million to $793 million. ANI shares have climbed 29% since the beginning of the year. The ...